
Adaptiiv Medical Technologies Inc., a Canadian company specializing in medical device and software development, is working with HP Inc. and Varian, a Siemens Healthineers company, to improve the quality and accessibility of personalised cancer care for patients in the United States by using 3D printed medical devices.
Adaptiiv Medical Technologies Inc. has a software platform that works in conjunction with 3D printing to create medical devices for use in radiation oncology. Adaptiiv is shaping the future of personalized healthcare through innovation and collaboration with industry leaders throughout the world.
Enhancing Radiation Oncology with 3D Printed Medical Devices
HP’s Multi Jet Fusion platform gives you access to cutting-edge 3D printing technology for producing high-quality, flexible, patient-specific parts at high throughput. HP 3D printing is appropriate for use in healthcare due to the speed, quality, and cost savings gained from HP’s scalable manufacturing processes.
“The combined technology scale of HP and Varian, along with the leading-edge personalization workflow of Adaptiiv, provides the improved solution that clinicians and patients deserve. HP is proud to be a part of this collaboration to help advance the treatment of cancers worldwide.”
– Louis Kim, Vice President, 3D Printing at HP
In addition, Adaptiiv will collaborate with Varian to increase access to personalised, patient-specific 3D printed medical devices. Varian has been developing, building, and delivering innovative cancer care technologies and solutions to clinical partners around the world for over 70 years, assisting them in treating millions of patients each year. Varian’s commitment to meeting changing customer needs and improving the patient experience is strengthened by this agreement.
Ben Moga, Director, Strategic Alliances and Synergy Investments at Varian shared his views on the collaboration saying, “We are energized by Adaptiiv’s innovation and this opportunity with HP to further expand our cancer care ecosystem. Addressing our customers’ needs is our top priority, and we are confident that this commercial commitment will help us do just that by advancing interoperability with Adaptiiv’s 3D printed medical devices for external beam radiation therapy.”
“This is a tremendous milestone for Adaptiiv’s vision to democratize personalization in radiation treatment. Collaborating with brands like HP and Varian who stand for quality and innovation will ensure our solutions reach patients around the world. The last mile of radiation therapy needs to evolve and our solutions provide greater access to personalized care, while improving treatment and creating workflow efficiencies for cancer centres around the world.”
– Alex Dunphy, CEO, Adaptiiv
Adaptiiv received FDA 510(k) clearance earlier this year for its Adaptiiv On Demand service, which manufactures and delivers 3D printed patient-specific medical devices. 3D printed medical devices conform to patient anatomy, improving dose delivery accuracy, while integrating Adaptiiv software into clinical workflows improves efficiencies by reducing patient set up time in CT simulation and on the treatment unit.